Stay updated on GeneNews LimitedPress Releases

Sign up to get notified when there's something new on the GeneNews LimitedPress Releases page.
Latest website image capture
Clouds background image

Latest updates to the GeneNews LimitedPress Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    The press releases listing now shows 506 results and includes a new entry titled 'FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer' dated 10 Jun 2026, while the older 'Genentech Provides Update on Phase III persevERA Study in ER-Positive Advanced Breast Cancer' dated 08 Mar 2026 was removed.
    Difference
    0.8%
    Check dated 2026-06-12T16:21:40.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    New press releases were added to the listing, including the FDA NDA acceptance for Genentech’s Giredestrant and upcoming obesity data presentations. Older releases were removed from the listing and minor site links like 'Our Focus on Obesity' and 'CA ALPR Privacy Policy' were added.
    Difference
    4%
    Check dated 2026-06-05T12:14:21.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The press releases listing now shows 503 results and adds new May 18, 2026 (ASCO data) and May 15, 2026 (ctDNA-guided Tecentriq adjuvant bladder cancer) entries. An entry for the persevERA study was removed or altered.
    Difference
    3%
    Check dated 2026-05-22T09:28:21.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Two new press releases were added to the listing (including ARVO 2026 coverage and a campaign with Damon Wayans and diaTribe); two older items were removed, increasing the total results from 499 to 501.
    Difference
    3%
    Check dated 2026-04-30T19:10:27.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The Press Releases results list updates to show new items dated in April 2026, including: “Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68%…” and “Genentech’s Fenebrutinib Significantly Reduced Relapses…” along with an FDA acceptance notice for Gazyva for lupus. Older entries with 2026 January–February dates (including multiple titled research/investment announcements) are removed from the visible results.
    Difference
    3%
    Check dated 2026-04-23T15:30:36.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    New March 2026 press releases were added (e.g., persevErA study update and ALLEGORY data), and several December 2025 releases were removed.
    Difference
    3%
    Check dated 2026-03-11T17:25:11.000Z thumbnail image

Stay in the know with updates to GeneNews LimitedPress Releases

Enter your email address, and we'll notify you when there's something new on the GeneNews LimitedPress Releases page.